News
Eyecelerator Kicks Off 2021 Schedule With Free Live Stream on Financing in the Time of COVID
February 22, 2021
Registration now open for the March 3rd event featuring leaders in ophthalmology and investing.
Oct. 26, 2020
AAO/ASCRS joint venture essential to accelerating innovation.
Eyecelerator Conference at AAO 2020 Goes 100% Virtual
Jul. 13, 2020
In light of epidemiological projections, government regulations and public health mandates, Eyecelerator has been forced to cancel the in-person portion of its November conference and will deliver its ophthalmic innovation program entirely online.
Eyecelerator Polls: Innovators Weigh-In on Post-COVID-19 Considerations
Jun. 2, 2020
Eyecelerator hosted a free series of live webcasts in April to provide insight into the future of ophthalmology following the pandemic.
Telemedicine Products were Focus of Eyecelerator's Third Live Stream Event
May 15, 2020
Eyecelerator’s third live stream, held April 29, showcased telemedicine and remote diagnosis technology in a nearly two-hour event with over 1600 registrants.
Eyecelerator Webinar Series Explores Ophthalmology in a Post-Pandemic World
April 24, 2020
Eyecelerator™ is hosting a series of free, live webinars to provide insight into what’s on the horizon for ophthalmic businesses, ophthalmologists and patients following the pandemic.
AAO and ASCRS Launch Eyecelerator™ Joint Venture
December 9, 2019
The American Academy of Ophthalmology and ASCRS have finalized their 2020 plans and selected leadership for their powerful new partnership to advance ophthalmic innovation with the next generation of business innovation conferences.
Leading Ophthalmic Organizations Partner for Next Generation of Business Innovation
October 8, 2019
Two of the world’s largest ophthalmic organizations, the American Academy of Ophthalmology and ASCRS, today announced a new collaboration to advance eye care with new innovation conferences coming in 2020. Eyecelerator™ will help accelerate the growth and success of companies focused on new therapies for eye disorders.